Long-term switching between ranibizumab and aflibercept in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy

被引：0
|
作者：
Jae Hui Kim
Jong Woo Kim
Chul Gu Kim
Dong Won Lee
机构：
[1] Kim’s Eye Hospital,Department of Ophthalmology
来源：
Graefe's Archive for Clinical and Experimental Ophthalmology | 2020年 / 258卷
关键词：
Age-related macular degeneration; Choroidal neovascularization; Polypoidal choroidal vasculopathy; Switching; Ranibizumab; Aflibercept;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1677 / 1685
页数：8
相关论文
共 50 条
  • [1] Long-term switching between ranibizumab and aflibercept in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
    Kim, Jae Hui
    Kim, Jong Woo
    Kim, Chul Gu
    Lee, Dong Won
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2020, 258 (08) : 1677 - 1685
  • [2] Long-term outcomes of ranibizumab vs. aflibercept for neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
    Jin, Ki Won
    Kim, Jae Hui
    Park, Jun Young
    Park, Sang Jun
    Park, Kyu Hyung
    Lee, Joo Yong
    Woo, Se Joon
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [3] Long-term outcomes of ranibizumab vs. aflibercept for neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
    Ki Won Jin
    Jae Hui Kim
    Jun Young Park
    Sang Jun Park
    Kyu Hyung Park
    Joo Yong Lee
    Se Joon Woo
    Scientific Reports, 11
  • [4] Effects of aflibercept for ranibizumab-resistant neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
    Yu Kawashima
    Akio Oishi
    Akitaka Tsujikawa
    Kenji Yamashiro
    Masahiro Miyake
    Naoko Ueda-Arakawa
    Munemitsu Yoshikawa
    Ayako Takahashi
    Nagahisa Yoshimura
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2015, 253 : 1471 - 1477
  • [5] Effects of aflibercept for ranibizumab-resistant neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
    Kawashima, Yu
    Oishi, Akio
    Tsujikawa, Akitaka
    Yamashiro, Kenji
    Miyake, Masahiro
    Ueda-Arakawa, Naoko
    Yoshikawa, Munemitsu
    Takahashi, Ayako
    Yoshimura, Nagahisa
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2015, 253 (09) : 1471 - 1477
  • [6] Polypoidal Choroidal Vasculopathy Masquerading as Neovascular Age-Related Macular Degeneration Refractory to Ranibizumab
    Stangos, Alexandros N.
    Gandhi, Jagdeep Singh
    Nair-Sahni, Jayashree
    Heimann, Heinrich
    Pournaras, Constantin J.
    Harding, Simon P.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2010, 150 (05) : 666 - 673
  • [7] Five-Year Reactivation After Ranibizumab or Aflibercept Treatment for Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy
    Kim, Jae Hui
    Kim, Jong Woo
    Kim, Chul Gu
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2021, 37 (09) : 525 - 533
  • [8] Switching between ranibizumab and aflibercept for the treatment of neovascular age-related macular degeneration
    Mantel, Irmela
    Gillies, Mark C.
    Souied, Eric H.
    SURVEY OF OPHTHALMOLOGY, 2018, 63 (05) : 638 - 645
  • [9] Four-Year Outcome of Aflibercept for Neovascular Age-Related Macular Degeneration and polypoidal choroidal vasculopathy
    Nishikawa, Keiichi
    Oishi, Akio
    Hata, Masayuki
    Miyake, Masahiro
    Ooto, Sotaro
    Yamashiro, Kenji
    Miyata, Manabu
    Tamura, Hiroshi
    Ueda-Arakawa, Naoko
    Takahashi, Ayako
    Kawashima, Yu
    Tsujikawa, Akitaka
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [10] Intravitreal aflibercept for submacular hemorrhage secondary to neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
    Jae Hui Kim
    Chul Gu Kim
    Dong Won Lee
    Su Jin Yoo
    Young Ju Lew
    Han Joo Cho
    Joo Yeon Kim
    Seok Hyun Lee
    Jong Woo Kim
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2020, 258 : 107 - 116
12345